Tag: life sciences
-
Biotech Gains Antibody Discovery, Manufacturing Funds
A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics.
-
A.I.-Aided Method Predicts Glaucoma Progression
Clinical trial results show a technique visualizing cells in the retina and analyzed with an algorithm accurately predicts the progression of glaucoma.
-
Stroke Found in More Young Adult Covid-19 Patients
An analysis of medical records shows individuals age 30 to 50 with Covid-19 infections are more likely to experience a stroke than their non-infected counterparts.
-
Trial Tests Blood Pressure Drug as Covid-19 Treatment
A common type of blood pressure drug will soon be tested in a clinical trial as a treatment for severe cases of Covid-19 infections.
-
NIH Opens Covid-19 Diagnostic Test Challenge
National Institutes of Health began a competition for new diagnostic tests that can better determine the extent of Covid-19 infections in the U.S.
-
Oxford, AstraZeneca Partner on Covid-19 Vaccine
AstraZeneca agreed today to help develop, manufacture, and distribute a candidate vaccine to prevent Covid-19 infections designed by University of Oxford.
-
Blood Test Detects Multiple Early Cancers
A clinical trial enrolling some 10,000 women demonstrates the feasibility of a routine blood test to screen for multiple types of cancer in their early stages.
-
Trial to Test Many Covid-19 Lung Disease Treatments
A clinical trial designed to make quick changes to accommodate new conditions plans to assess 10 to 20 drugs for a serious lung complication from Covid-19 infections.
-
Univ Building Single Covid-19 Diagnostic, Antibody Test
A university bio-engineering lab is developing a single point-of-care test that detects both Covid-19 viruses in nasal swabs and antibodies in blood samples.
-
Limited Covid-19 Benefits Found for Arthritis Drug
A clinical trial testing an arthritis drug to treat Covid-19 patients shows the drug helps the most critical patients, but not others with advanced infections.